Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Start 7-day free trial → Log in

Maribavir · Livtencity, TAK-620

Small molecule · Inhibitor of CMV pUL97 kinase · developed by Takeda Pharms Usa

Approved FDA, Nov 2021

TAK Developer

1 Registered trials

What is Maribavir?

Maribavir (LIVTENCITY) is a small-molecule inhibitor of cytomegalovirus (CMV) pUL97 kinase.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as: Livtencity, TAK-620
Drug type: Small molecule
Targets: CMV pUL97 kinase
Mechanism: Inhibitor of CMV pUL97 kinase
Therapy area: Infectious disease
Developer: Takeda Pharms Usa (TAK)
FDA status: Approved as Livtencity (November 23, 2021), NDA215596 · FDA label
UNII: PTB4X93HE1

✅ FDA-approved uses

Post-transplant CMV infection/disease refractory to ganciclovir, valganciclovir, cidofovir or foscarnet

From the indications section of the FDA label (version of Jan 27, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

Trial	Phase	Condition	Status	Sponsor
NCT06439342	Phase 3	Cytomegalovirus (CMV)	Completed	TAK

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Cytomegalovirus (CMV)

More from Takeda Pharms Usa

Susoctocog Alfa FDA approved Vedolizumab FDA approved Vonicog Alfa FDA approved Elritercept Phase 3 GDX012 Phase 1/2 IGI Phase 3 Mezagitamab Phase 3 MNI-792 Phase 1 Pevonedistat Phase 2/3 Soticlestat Phase 3 TAK-186 Phase 1/2 TAK-188 Phase 1/2

Sources

Updated Oct 3, 2026. Something wrong or missing? Report it on the TAK page.

Follow TAK, the company behind Maribavir

See TAK's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

TAK catalysts and pipeline →

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z